Archford Capital Strategies LLC lifted its position in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 10.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,237 shares of the healthcare company's stock after purchasing an additional 1,350 shares during the quarter. Archford Capital Strategies LLC's holdings in UiPath were worth $259,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of PATH. AdvisorNet Financial Inc raised its position in UiPath by 48.6% in the 2nd quarter. AdvisorNet Financial Inc now owns 3,120 shares of the healthcare company's stock valued at $57,000 after buying an additional 1,020 shares during the last quarter. Freestone Capital Holdings LLC raised its position in UiPath by 24.8% in the 4th quarter. Freestone Capital Holdings LLC now owns 5,307 shares of the healthcare company's stock valued at $229,000 after buying an additional 1,054 shares during the last quarter. Prospera Financial Services Inc purchased a new stake in UiPath in the 1st quarter valued at $27,000. First Republic Investment Management Inc. raised its position in UiPath by 1.6% in the 1st quarter. First Republic Investment Management Inc. now owns 91,074 shares of the healthcare company's stock valued at $1,966,000 after buying an additional 1,410 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. grew its stake in UiPath by 3.8% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 40,993 shares of the healthcare company's stock valued at $885,000 after purchasing an additional 1,506 shares during the period. 51.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CFO Ashim Gupta sold 10,000 shares of the stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $13.74, for a total transaction of $137,400.00. Following the sale, the chief financial officer now owns 1,377,266 shares of the company's stock, valued at approximately $18,923,634.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UiPath news, CAO Hitesh Ramani sold 22,800 shares of the firm's stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $20.70, for a total value of $471,960.00. Following the sale, the chief accounting officer now owns 426,799 shares of the company's stock, valued at approximately $8,834,739.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Ashim Gupta sold 10,000 shares of the firm's stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $13.74, for a total value of $137,400.00. Following the completion of the sale, the chief financial officer now directly owns 1,377,266 shares in the company, valued at approximately $18,923,634.84. The disclosure for this sale can be found here. In the last quarter, insiders have sold 162,800 shares of company stock valued at $3,129,960. Corporate insiders own 31.88% of the company's stock.

Wall Street Analyst Weigh In

UiPath Price Performance

Shares of PATH opened at $13.79 on Wednesday. The stock's 50-day simple moving average is $17.88 and its 200 day simple moving average is $19.81. UiPath Inc. has a 52-week low of $12.21 and a 52-week high of $59.57.

UiPath (NYSE:PATH – Get Rating) last issued its quarterly earnings data on Tuesday, September 6th. The healthcare company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.09. The business had revenue of $242.22 million for the quarter, compared to analysts' expectations of $230.68 million. UiPath had a negative return on equity of 19.19% and a negative net margin of 42.98%. The firm's quarterly revenue was up 23.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.17) EPS. Sell-side analysts anticipate that UiPath Inc. will post -0.63 earnings per share for the current year.

UiPath Profile

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

• Get a free copy of the StockNews.com research report on UiPath (PATH)
• 3 Airline Stocks Stuck in a Holding Pattern
• Roku Stock is Down but Not Out
• If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
• Is Ford Rolling To A Rebound After Its Q3 Warning
• Has AMD stock stock fallen too far?

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Get Rating).

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.